Literature DB >> 1673049

The donation and sale of blood by intravenous drug users.

D D Chitwood1, J B Page, M Comerford, J A Inciardi, C B McCoy, E Trapido, S H Lai.   

Abstract

In spite of efforts to dissuade intravenous drug users (IVDUs) from donating or selling blood, some continue to do so. As part of a longitudinal study, 915 IVDUs in South Florida were interviewed concerning their history of donation or sale of blood and tested for antibodies to HIV-1 and HTLV-I/II. Approximately 17 percent had either donated or sold blood during 1985 through 1988; most contributors (80.4 percent) sold to commercial blood services. IVDUs who had donated/sold blood were more likely to be male and not in drug treatment than were those who had not contributed blood. IVDUs not in treatment at the time of interview were more likely than IVDUs in treatment to have sold blood. Of those who had donated/sold blood since 1985, 19.6 percent subsequently tested positive for antibodies to HIV-1 and 5.7 percent were positive for antibodies to HTLV-I/II. Increased effort is required to screen prospective donors and sellers, particularly at commercial blood banks.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; Miami-Dade County

Mesh:

Year:  1991        PMID: 1673049      PMCID: PMC1405081          DOI: 10.2105/ajph.81.5.631

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  Laboratory evidence of active HIV-1 infection in Canadians with hemophilia associated with administration of heat-treated factor VIII.

Authors:  P Neumann; M O'Shaughnessy; R Remis; C Tsoukas; D Lepine; M Davis
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

2.  Declining prevalence of HIV-seropositive blood donors.

Authors:  P M Ness; D K Douglas; M Harper; B F Polk
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

3.  Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

Authors:  D T Imagawa; M H Lee; S M Wolinsky; K Sano; F Morales; S Kwok; J J Sninsky; P G Nishanian; J Giorgi; J L Fahey
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

4.  Prevalence of HTLV-III antibody in American blood donors.

Authors:  J B Schorr; A Berkowitz; P D Cumming; A J Katz; S G Sandler
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

5.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

6.  Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.

Authors:  J W Ward; S D Holmberg; J R Allen; D L Cohn; S E Critchley; S H Kleinman; B A Lenes; O Ravenholt; J R Davis; M G Quinn
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

7.  Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

Authors:  A E Williams; C T Fang; D J Slamon; B J Poiesz; S G Sandler; W F Darr; G Shulman; E I McGowan; D K Douglas; R J Bowman
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

8.  Sociodemographic and behavioral characteristics of HIV antibody-positive blood donors.

Authors:  P D Cleary; E Singer; T F Rogers; J Avorn; N Van Devanter; S Soumerai; S Perry; J Pindyck
Journal:  Am J Public Health       Date:  1988-08       Impact factor: 9.308

9.  Blood and plasma donations among a cohort of intravenous drug users.

Authors:  K E Nelson; D Vlahov; J Margolick; M Bernal; E Taylor
Journal:  JAMA       Date:  1990-04-25       Impact factor: 56.272

  9 in total
  2 in total

1.  Geographic location of commercial plasma donation clinics in the United States, 1980-1995.

Authors:  Robert C James; Cameron A Mustard
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Blood Donation, Payment, and Non-Cash Incentives: Classical Questions Drawing Renewed Interest.

Authors:  Alena M Buyx
Journal:  Transfus Med Hemother       Date:  2009-09-21       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.